News & Analysis on Clinical Trial Services & Contract Research And Development
GlaxoSmithKline are to commission the pharmaceutical industry's first in-house Accelerator Mass Spectrometry (AMS) facility, with the primary aim of providing information on human metabolite formation of new drug candidates and detail pathways of drug...
A collaboration agreement to identify and develop an improved variant of CT500, a non-antibody protein with antagonist activity against HMGB1 has been established, paving the way for applications, to treat tumours and autoimmune diseases.
An updated version of a database that details GPCR and ADME/Drug-Drug Interactions has been released by Aureus Pharma who believe this system will prove invaluable in identifying, validating and prioritise new targets and ligands for drug discovery.
The pharmaceutical industry has announced it would introduce a central, accessible database to improve the communication of the clinical study results of marketed drugs.
The first natural human model for specific Hodgkin's and non-Hodgkin's lymphomas has been identified by scientists whose studies into cancer immunity in chickens could pave the way for an effective drug therapy to treat one of the most common cancers...
US drug delivery company MAP Pharmaceuticals has raised $30 million in a second-round stock financing with several top-tier biotechnology investors and says it will use the proceeds to progress its inhaled steroid and Tempo Inhaler technology.
The US Food and Drug Administration has failed to reach a decision on approving a growth hormone (hGH) product developed by Novartis' generics subsidiary Sandoz in what is emerging as a test case for the development of generic copies of biological drugs.
ELGA Process Water has announced a new addition to its ORION range of packaged water purification systems for pharmaceutical and cosmetics manufacturing, healthcare and biotechnology
The latest study to lament the cost of implementing the European Union's REACH system has predicted dire consequences for the EU's Gross Domestic Product, production base and innovative strength.